BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL

被引：0
|
作者：
Medina Pestana, J. [1 ]
Grinyo, J. [2 ]
Vanrenterghem, Y. [3 ]
Becker, T. [4 ]
Florman, S. [5 ]
Lang, P. [6 ]
Rial, M. del C. [7 ]
Schnitzler, M. [8 ]
Duan, T. [9 ]
Block, A. [9 ]
Durrbach, A. [10 ]
机构：
[1] Hosp Rim & Hipertensao, Sao Paulo, Brazil
[2] Univ Hosp Bellvitge, Barcelona, Spain
[3] Univ Hosp Leuven, Louvain, Belgium
[4] Hannover Med Sch, D-30623 Hannover, Germany
[5] Mt Sinai Med Ctr, New York, NY 10029 USA
[6] Hop Henri Mondor, F-94010 Creteil, France
[7] Inst Nefrol, Buenos Aires, DF, Argentina
[8] St Louis Univ, St Louis, MO 63103 USA
[9] Bristol Myers Squibb Co, Princeton, NJ USA
[10] Hop Bicetre, Le Kremlin Bicetre, France
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL
    Medina Pestana, Jose O.
    Grinyo, Josep M.
    Vanrenterghem, Yves
    Becker, Thomas
    Florman, Sander
    Lang, Philippe
    Rial, Maria del C.
    Schnitzler, Mark A.
    Duan, Tao
    Block, Alan
    Durrbachll, Antoine
    TRANSPLANT INTERNATIONAL, 2011, 24 : 68 - 68
  • [2] Belatacept Compared with Cyclosporine in Renal Allograft Recipients of Extended Criteria Donor Kidneys: 3-Year Outcomes from the Phase III BENEFIT-EXT Trial.
    Medina Pestana, J.
    Grinyo, J.
    Vanrenterghem, Y.
    Becker, T.
    Florman, S.
    Lang, P.
    Rial, M. del C.
    Schnitzler, M.
    Duan, T.
    Block, A.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 349 - 349
  • [3] Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
    Pestana, J. O. M.
    Grinyo, J. M.
    Vanrenterghem, Y.
    Becker, T.
    Campistol, J. M.
    Florman, S.
    Garcia, V. D.
    Kamar, N.
    Lang, P.
    Manfro, R. C.
    Massari, P.
    Rial, M. D. C.
    Schnitzler, M. A.
    Vitko, S.
    Duan, T.
    Block, A.
    Harler, M. B.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 630 - 639
  • [4] DONOR SUB-TYPE ANALYSIS OF THREE-YEAR OUTCOMES FROM A PHASE III STUDY OF BELATACEPT IN RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS (BENEFIT-EXT TRIAL)
    Muehlbacher, Ferdinand
    Becker, Thomas
    Campistol, Josep M.
    Carvalho, Deise B. M.
    Florman, Sander
    Lang, Philippe
    Duan, Tao
    Agarwal, Mamta
    Larsen, Christian P.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 221 - 222
  • [5] Impact of Donor Age on Three-Year Outcomes in Recipients of Extended Criteria Kidneys Treated with Belatacept vs Cyclosporine in BENEFIT-EXT Trial.
    Budde, K.
    Morales, J.
    Blancho, G.
    Muehlbacher, F.
    Lehner, F.
    Rice, K.
    Pupim, L.
    Aigner, S.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 182 - 183
  • [6] IMPACT OF DONOR AGE ON 3-YEAR OUTCOMES OF EXTENDED CRITERIA DONOR KIDNEY RECIPIENTS IN BENEFIT-EXT
    Lehner, Frank
    Budde, Klemens M. D.
    Morales, Jose M.
    Blancho, Gilles
    Muehlbacher, Ferdinand
    Rice, Kim
    Pupim, Lara
    Aigner, Sigrid
    Vincenti, Flavio
    TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
  • [7] Outcomes as a Function of Donor Criteria from a Phase III Study of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT-EXT).
    Florman, Sander
    Durrbach, Antoine
    Larsen, Christian
    Pestana, Jose Medina
    Vanrenterghem, Yves
    Vincenti, Flavio
    Block, Alan
    Garg, Pushkal
    Copley, J. Brian
    Xing, Jun
    Grinyo, Josep
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 150 - 150
  • [8] Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study
    Durrbach, A.
    Pestana, J. M.
    Florman, S.
    del Carmen Rial, M.
    Rostaing, L.
    Kuypers, D.
    Matas, A.
    Wekerle, T.
    Polinsky, M.
    Meier-Kriesche, H. U.
    Munier, S.
    Grinyo, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3192 - 3201
  • [9] THREE YEAR OUTCOMES BY DONOR TYPE IN PHASE III STUDIES OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT AND BENEFIT-EXT)
    Florman, S.
    Becker, T.
    Bresnahan, B.
    Chevaile-Ramos, A.
    Carvalho, D.
    Muehlbacher, F.
    O'Connell, P.
    Duan, T.
    Agarwal, M.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 51 - 51
  • [10] BENEFIT-EXT STUDY TWO YEAR OUTCOMES: BELATACEPT VS CYCLOSPORINE (CSA) IN EXTENDED CRITERIA DONOR (ECD) KIDNEY TRANSPLANTS
    Russ, G.
    Durrbach, A.
    Larsen, C. P.
    Pestana, Medina J.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Christina, Xinos
    Grinyo, J.
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A2 - A2
12345